MediBeacon Inc.
1100 Corporate Square Drive
Helix Center, Suite 175
St. Louis
Missouri
63132
United States
Tel: 314-269-5808
Website: http://www.medibeacon.com/
Email: info@medibeacon.com
About MediBeacon Inc.
MediBeacon was formed in 2012 specifically to acquire the optical diagnostic program from Mallinckrodt, the Pharmaceuticals business of Covidien. MediBeacon’s mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological disease in the human population. Several product concepts in these arenas are contained in the MediBeacon Intellectual Property (IP) portfolio.YEAR FOUNDED: 2012
LEADERSHIP:
Founder and CEO: Steven J. Hanley
Founder and CSO: Richard B. Dorshow
CLINICAL TRIAL:
Please click here for clinical trial information.
FOLLOW MEDIBEACON:
Tweets by MediBeacon
5 articles about MediBeacon Inc.
-
MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System
11/16/2022
MediBeacon approaching completion of Phase 3 study focused on kidney disease; Has submitted three of five required PMA modules needed for FDA approval.
-
MediBeacon Enters into $30 Million Investment and Exclusive Commercialization Partnership in Greater China with Huadong Medicine
7/31/2019
MediBeacon and Huadong Medicine will collaboratively work to reach regulatory approval on MediBeacon's entire portfolio of assets in Greater China [31-July-2019] ST. LOUIS , July 31, 2019 /PRNewswire/ -- MediBeacon Inc ., whose largest shareholder is Pansend Life Sciences, LLC, a subsidiary of HC2 Holdings, Inc. (NYSE MKT: HCHC), announced today that they have entere
-
FDA Grants Breakthrough Device Status for MediBeacon's Transdermal GFR Measurement System
10/22/2018
MediBeacon's Breakthrough Device is Intended to Measure GFR in Patients with Impaired or Normal Kidney Function
-
MediBeacon Completes Successful Clinical Study Of Transdermal Glomerular Filtration Rate Monitor On Impaired Kidney Function Subjects
3/2/2017
-
MediBeacon Collaborates With Washington University In $1.1 Million Grant For Groundbreaking Research In Global Health And Development
10/18/2016